NUS Medicine researchers identify blood protein signatures linked to cerebrovascular disease and future health risks, with ...
Edesa Biotech, Inc., a Canada-based clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, and KYORIN Pharmaceutical Co, a leading ...
France-based Laboratoires Pierre Fabre and China's XtalPi have announced an agreement under which they will collaborate on the discovery of novel clinical candidates across a number of research ...
Under the terms of the agreement, Nxera will receive an upfront payment of $100 million. Nxera is also eligible to receive up ...
Temasek Life Sciences Laboratory launches APOHI to strengthen regional disease early warning, beginning with a zoonotic ...
Waters Corporation has announced AI-Powered Peak Integration, the next step in its strategy to build intelligent AI, machine ...
South Korea-based International Vaccine Institute (IVI) has joined Bayer AG and the Coalition for Epidemic Preparedness ...
Abbott and Novo expand partnership to launch Plosbrio® broadening access to semaglutide for advanced diabetes care across ...
The National Comprehensive Cancer Network ® (NCCN ®) has announced the signing of a new agreement with the Viet Nam National ...
Minghui Pharmaceutical and ASKA Pharmaceutical Enter into Exclusive License Agreement for the IGF-1R Antibody in Japan ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results